IVI [to 25 July 2015]
:: Dr. In-Kyu Yoon Appointed as Director of the Dengue Vaccine Initiative
WASHINGTON, DC – July 24, 2015 – The Dengue Vaccine Initiative (DVI) a consortium comprised of the International Vaccine Institute, the Johns Hopkins University’s International Vaccine Access Center, Sabin Vaccine Institute and the World Health Organization, is delighted to announce the appointment of Dr. In-Kyu Yoon as its new Director. Dr. Yoon, former Chief of the Department of Virology, Armed Forces Research Institute Medical Sciences in Bangkok, Thailand, will lead DVI starting August, 2015.
“We greatly look forward to Dr. Yoon’s leadership of DVI,” said Dr. Jerome Kim, the International Vaccine Institute’s Director General. “Dr. Yoon’s extensive research experience and knowledge of dengue and vaccine clinical trials will further strengthen DVI’s management and operations. His experience will be welcomed by the International Vaccine Institute as he can also provide additional scientific leadership at the Institute.”
In his previous position, Dr. Yoon investigated arbovirus and respiratory virus infections including clinical trials of candidate vaccines. He has conducted research on the epidemiology, pathophysiology and immunology of dengue and other emerging infectious diseases, was a faculty member of the Uniformed Services University of the Health Sciences in Maryland, United States and authored over 70 publications and provided clinical care in a variety of civilian and military settings internationally…
…“I’m excited to lead the Dengue Vaccine Initiative during this critical period in the development and implementation of dengue vaccines. DVI and PDVI have played a crucial role over the past 12 years in advancing the field of dengue vaccines. As we move forward, DVI will continue to work diligently to promote measures to prevent and control this global problem” commented Dr. Yoon on his new endeavor